Max Robotics — Global Service Robot Directory + US Certification

About

Christopher Soll is a surgical researcher whose work sits at the intersection of minimally invasive surgery and emerging robotic technologies, with a particular focus on cholecystectomy techniques for benign gallbladder disease. His research has made meaningful contributions to the comparative evaluation of robot-assisted and laparoscopic approaches to single-incision surgery, helping to clarify the clinical value of the da Vinci Single-Site™ platform in real-world surgical settings. Soll's most impactful contribution is a randomized controlled trial published in 2018 comparing robot-assisted versus laparoscopic single-incision cholecystectomy, which has accumulated 80 citations and stands as a key reference in the minimally invasive surgery literature. Complementing this, his 2017 protocol paper outlined the rigorous methodological framework underpinning the trial, demonstrating his commitment to evidence-based surgical research. A further single-blinded randomized controlled trial published in 2018 reinforced his findings, adding 17 additional citations to his growing body of work. Across his research, Soll has helped surgeons better understand the safety, feasibility, and learning curve advantages associated with robotic single-site surgery. His work provides valuable guidance for surgical departments navigating the adoption of robotic platforms and continues to inform training and practice standards worldwide.